September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Zeaxanthin inhibits Growth and Invasion of Human Uveal Melanoma in Nude Mouse Model
Author Affiliations & Notes
  • Dan-Ning Hu
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Xiaoliang Leon Xu
    Memorial Sloan-Kettering Cancer Center, New York, New York, United States
  • Codrin Eugen Iacob
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Adrienne Jordan
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Sandipkumar Gandhi
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Dennis L Gierhart
    ZeaVision LLC, Chesterfield, Montana, United States
  • Richard B Rosen
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Dan-Ning Hu, Mount Sinai Health System (P); Xiaoliang Xu, None; Codrin Iacob, None; Adrienne Jordan, None; Sandipkumar Gandhi, None; Dennis Gierhart, ZeaVision LLC (I); Richard Rosen, Mount Sinai Health System (P)
  • Footnotes
    Support  Dennis Gierhart Charitable Gift Fund
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4104. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Dan-Ning Hu, Xiaoliang Leon Xu, Codrin Eugen Iacob, Adrienne Jordan, Sandipkumar Gandhi, Dennis L Gierhart, Richard B Rosen; Zeaxanthin inhibits Growth and Invasion of Human Uveal Melanoma in Nude Mouse Model. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4104.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The effects of zeaxanthin on uveal melanoma in experimental animal models remain unknown. We found that zeaxanthin inhibited the growth and induced apoptosis of human uveal melanoma cells in vitro. We hypothesize that zeaxanthin may also have effects on uveal melanoma in vivo. The present study investigated the in vivo effects of zeaxanthin on human uveal melanoma in a nude mouse model.

Methods : Cultured human uveal melanoma cells from an immortal cell line were inoculated into the choroid of nude mice. Mice were randomly divided into control group (without treatment of zeaxanthin), zeaxanthin low group and zeaxanthin high group (treated with intra-choroidal injection of zeaxanthin at 0.171 mg and 0.684 mg, respectively). After 21 days, mice were sacrificed and the eyes enucleated. Gross appearances and tumor mass was determined. Histopathological analysis was performed in hematoxylin and eosin stained frozen sections. Melanoma developed rapidly in the control group.

Results : Tumor-bearing eye mass in the control group (21.3 ± 3.5 mg, mean±SD) were significantly greater than those in zeaxanthin low group (16.1 ± 3.4 mg) and zeaxanthin high group (12.4 ± 3.2 mg) (P < 0.05). Histopathological study revealed that melanoma in the controlled eyes occupied a large part of the eye, was epithelioid in morphology and with numerous mitotic figures. Scleral perforation and extraocular extension were observed in half of the eyes. Melanomas in zeaxanthin treated eyes were significantly smaller than those in the controls, with many necrosis and apoptosis areas and no extraocular extension could be found. Quantitative image analysis revealed that the tumor size was reduced by 56% in zeaxanthin low group and 92% in zeaxanthin high group as compared to the controls (P < 0.05).

Conclusions : Our results are consistent with our hypothesis and this study demonstrated that intraocular administration of zeaxanthin significantly inhibits the growth and invasion of human uveal melanoma in nude mice, suggesting that zeaxanthin may be a promising agent to be explored for the prevention and treatment of uveal melanoma.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×